## **Core Concept**
Vigabatrin is an antiepileptic medication that works through a specific mechanism to control seizures. It is primarily used in the treatment of epilepsy and certain types of seizures. The drug's action is focused on the neurotransmitter gamma-aminobutyric acid (GABA).

## **Why the Correct Answer is Right**
Vigabatrin acts by inhibiting the action of **GABA transaminase**, the enzyme responsible for the breakdown of GABA. By preventing the breakdown of GABA, vigabatrin increases the concentration of GABA in the brain, enhancing inhibitory neurotransmission and thus reducing neuronal excitability. This mechanism is crucial for its antiepileptic effects.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because vigabatrin's primary mechanism does not involve blocking voltage-gated sodium channels, which is a mechanism of action for drugs like phenytoin and carbamazepine.
- **Option B:** This option is incorrect as vigabatrin does not act by enhancing the activity of glutamate receptors; instead, it increases GABAergic activity.
- **Option D:** This option is incorrect because vigabatrin's action is not related to the blockade of calcium channels, a mechanism associated with certain other antiepileptic drugs.

## **Clinical Pearl / High-Yield Fact**
A significant clinical pearl regarding vigabatrin is its association with **permanent vision loss** (bilateral concentric visual field constriction) and **visual impairment**, which are serious side effects. This risk necessitates careful monitoring and discussion of risks with patients.

## **Correct Answer:** C. Inhibiting GABA transaminase.